Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.54
+0.12 (1.62%)
May 21, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 121.86 million as of May 21, 2026. Its market cap has decreased by -30.83% in one year.
Market Cap
121.86M
Enterprise Value
128.18M
Revenue
15.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.54
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 121.86M, an increase of 31.02%. That is a compound annual growth rate of 1.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 119.92M | 6.30% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 520.20M |
| Captor Therapeutics Spolka Akcyjna | 494.93M |
| Bioceltix | 417.10M |
| BIOTON | 370.07M |
| Syn2bio | 281.34M |
| Synthaverse | 220.10M |
| Molecure | 111.26M |
| NanoGroup | 101.46M |